Showing results (921-930 of 1,061) with videos related to
Sort By:
Pageof 107
Neurobiology of Aging|April 25, 2026
Predicting future cognitive impairment in preclinical Alzheimer's disease using amyloid PET and MRI: A multisite machine learning studyBraden Yang, Tom Earnest, Murat Bilgel, et al.Current Topics in Medicinal Chemistry|November 6, 2007
An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca's drug discovery programmesJeffrey S Albert, Niklas Blomberg, Alexander L Breeze, et al.Human Brain Mapping|April 24, 2025
MRI Distance Measures as a Predictor of Subsequent Clinical Status During the Preclinical Phase of Alzheimer's Disease and Related DisordersXinyi Zhang, Brian S Caffo, Anja Soldan, et al.Genetics|July 20, 2019
Hybrid Decay: A Transgenerational Epigenetic Decline in Vigor and Viability Triggered in Backcross Populations of Teosinte with MaizeWei Xue, Sarah N Anderson, Xufeng Wang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?David A Brown, Kenneth W Hance, Connie J Rogers, et al.Head & Neck|May 28, 2005
A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinomaColleen H Druzgal, Zhong Chen, Ning T Yeh, et al.Current Biology : CB|April 2, 2025
Duckweed genomes and epigenomes underlie triploid hybridization and clonal reproductionEvan Ernst, Bradley Abramson, Kenneth Acosta, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2016
Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapyA Servy, E Maubec, P E Sugier, et al.Cancer Detection and Prevention|April 3, 2003
Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern ChinaNan Hu, Wen-Jun Li, Hua Su, et al.The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptorsW L Rumsey, D Aharony, R A Bialecki, et al.Pageof 107